SciSparc's NeuroThera expands US patent filings on psychedelic-PEA combinations with ClearmindSep 24PartnershipSciSparc Ltd.
NRx reports Q2 2026 results, advances ketamine ANDA and DARPA-backed NRX-101 trialAug 17Quarterly updateketamineNRX Pharmaceuticals, Inc.
Sign inSign in